A series of lactone 1,4-dihydroquinoline derivatives 4 (4 and 4aa-4cm) was screened for in vitro antileishmanial activity against the promastigote form of Leishmania (Leishmania) amazonensis. Screening results indicate that all of the synthesized compounds significantly reduced the growth of promastigote forms of promastigotes of L. (L.) amazonensis. The cytotoxicity of the most active compounds was also measured on peritoneal macrophage cells. Compounds 4ah and 4bn showed better activities than other derivatives with IC 50 values of 6.22 and 9.05 μM, respectively, with selectivity index 22 and 15 times less toxicity to macrophages cells than to parasites, respectively. The experimental data propose that the compounds may be further investigated against amastigote forms and may contribute to the search of new candidates drugs for treatment of cutaneous leishmaniasis.
Introduction
Leishmaniasis are neglected tropical diseases caused by protozoan parasites of the Leishmania genus and transmitted by the bite of female sandfly vectors (Pace 2014) . These infections are endemic in 98 countries, with more than 12 million cases, and 350 million people living in an area at risk (Bhutta et al. 2014; Okwor and Uzonna 2016) . The expression of leishmaniasis depends on a complex interaction between the type of infecting species and host immune response. Infection may be asymptomatic or may manifest as cutaneous leishmaniasis (CL) that is pleiomorphic in presentation, mucocutaneous leishmaniasis (MCL), or visceral leishmaniasis (VL) that may be lethal if untreated (Desjeux 2004; Pace 2014) . In Latin America, Leishmania (Leishmania) amazonensis is responsible for a cutaneous diffuse form that in some cases may also result in visceral leishmaniasis (Torres-Guerrero et al. 2017) .
The treatment of CL and VL is based on the use of expensive and toxic drugs, and that to a great extent must be administered by the parenteral route. The most used drugs are derivatives of pentavalent antimony; however, in many areas of this disease, parasitic resistance is already widespread (Ponte-Sucre et al. 2017) . The second line of treatment is amphotericin B, an antifungal with a broad spectrum of action and that shows a high toxicity in the host (Fernández-García et al. 2017) . Its less toxic lipid formulation is extremely expensive and incompatible with treatment in developing countries (Kumar et al. 2009; Pace 2014; Durieu et al. 2016; Fernández-García et al. 2017) . Among the other drugs used in leishmaniasis therapy, miltefosine is the first oral treatment against VL, but its teratogenicity excludes the treatment of pregnant women and its slow turnover could promote the emergence of clinical parasite resistance (Singh et al. 2012; Durieu et al. 2016) .
Therefore, these factors justify the search for new chemical series in order to find an orally safe and active drug (Loedige 2015; Ashok et al. 2017) . The choice of the dihydroquinolinic nucleus associated with the lactonic ring is due to the presence of these pharmacophoric groups in several compounds with important leishmanicidal properties (Castaño et al. 2009; Reynolds et al. 2013; Coimbra et al. 2016) . As part of our ongoing interest on the antiparasitic activity of compounds, we have evaluated herein the leishmanicidal potential of 35 lactone 1,4-dihydroquinoline derivatives against the parasite L. (L.) amazonensis in vitro.
Results and discussion

Chemistry
The 1,4-dihydroquinoline lactone derivatives 4 and 4aa-4cm were obtained in a previous work of our research group from microwave-assisted multicomponent reaction between tetronic acid, aromatic aldehyde, and anilines in ethanol (Table 1) . These compounds showed interesting antimicrobial activities against oral bacteria (Laurentiz et al. 2018) . Derivatives 4a-4cn have three different groups of electron-donating substituents on the dihydroquinolinic ring (3,4,5-OCH 3 , 3,4-OCH 2 O, and 3,4-OCH 3 ) and on the benzyl ring with electron-donating or electron-withdrawing substituents: OCH 3 , OCH 2 O, OH, Cl, CF 3 , OBn, F, and NO 2 e SCH 3 .
Antileishmanicidal activities
A preliminary screening of 35 lactones 1,4-dihydroquinoline derivatives was performed at 100 μM against promastigote forms de L. (L.) amazonensis to select the most active compounds at higher concentrations.
Although the clinically relevant form of the parasite is the amastigote form, which shows metabolic differences from the extracellular forms, promastigotes can be used for fast screenings of potential compounds (Tempone et al. 2005; Martín-Montes et al. 2017; Silva et al. 2017) . Thus, in this study, we evaluated the effect of dihydroquinoline lactone derivatives against promastigote forms of L. (L.) amazonesis in vitro.
The compounds 4aa, 4ab, 4aj, 4bg, and 4bh showed a percentage of inhibition of cell growth of less than 50% at 24 h (Table 1) . The other compounds showing activity higher than 50% include the unsubstituted compound 4, however, only those with activity greater than 80% were submitted to additional assays in lower concentrations. Among the compounds with parasite activity above 80%, it was possible to observe that the compounds containing the nitro piperonal group as a substituent on the benzyl ring, independent of the substituent of the quinolinic moiety, are among the most active compounds (4an, 4bn, and 4cn). Compounds 4ah and 4ch containing the CF 3 group were also very active at this concentration.
The substitution on phenyl and dihydroquinoline rings had a considerable effect on potency of other derivatives in comparison with unsubstituted compound 4. All the evaluated compounds inhibited the growth of L. (L.) amazonensis promastigote forms to a greater or lesser degree, however, only those compounds that presented reduction on growth inhibition of promastigote forms with a percentage above 80% were evaluated at concentrations of 1.00-100 µM (Table 2) .
According to hit-and-lead criteria, a hit compound should demonstrate IC 50 < 10 µM against protozoan parasites and a selectivity index greater than 10-fold between the half-maximal cytotoxic concentration (CC 50 ) for the mammalian cell line and the IC 50 for parasite (Dardonville et al. 2009; Katsuno et al. 2015) . In this study, in promastigote activity assay at lower concentrations, the reported lactones 1,4-dihydroquinoline, displayed the growth of L. (L.) amazonensis promastigote forms with IC 50 value ranges of 2.62-73.50 µM (Table 2) . Among the reported compounds, analogs 4ae, 4ah, 4bi, and 4bn were more potent in inhibiting the L. Among the compounds containing R1 = 3,4,5-OCH 3 , 4ae and 4ah were more active with IC 50 values of 5.29 and 6.22 µM, respectively. Compound 4ae has electron donor substituents in para (OBn) and meta (OCH 3 ) positions, while compound 4ah has a single electron-withdrawing substituent in para (CF 3 ) position. The change of the OBn group for CF 3 and OCH 3 groups for H resulted in a small loss of activity, but contributed to enhance the selectivity index of 4ah by almost 20x in relation to 4ae. The nature of R2 and the degree of substitution for these two compounds mainly affected the selectivity index, showing that the hydrophobic and electronegative character of the CF3 group in addition to their smaller size contributed to the higher selectivity of 4ah on L. (L.) amazonensis promastigote forms. The compounds more active with R1 = OCH 2 O were 4bi and 4bn that have in common the nitro group connected to the phenyl ring. The presence of two OCH 3 groups on the phenyl ring (R2) contributes to the increase of 4bi activity in relation to 4bn, which presents the methylenedioxy group in the same position. These two groups of substituents in R2 have an electron donor character; however, the methylenedioxy group presents a more rigid character because it is a cycle and also has a greater hydrophobic character. Compound 4bi showed better activity (IC 50 = 2.62 μM, SI = 5.03), however, it was about three times less selective than 4bn (IC 50 = 9.05 μM, SI = 15.05). The compounds containing the 3,4-dimethoxy substituents on the 1,4-dihydroquinolinic moiety were the least active (4cd, 4ch, 4cm, and 4cn with IC 50 > 17 µM) independently of a substituent on the phenyl ring, however, these substituents on the dihydroquinolinic ring are not favorable to the leishmanicidal activity for this class of compounds.
Thus, the compounds with IC 50 values below 10.0 µM (Table 2) are those with 3,4,5-trimethoxy and 3,4-methylenedioxy substituents in the 1,4,-dihydroquinolinic moiety, i.e., these groups are favorable to the action of this class of compounds and, therefore, the choice of the substituent on the benzyl ring is determinant for the increase in leishmanicidal activity.
Regarding macrophage cytotoxicity, the less toxic compounds were 4ah and 4bn with CC 50 values of 139.20 and 136.27 µM, respectively. Compound 4bi was one of the most toxic, as well as 4ae, respectively, with CC 50 values of 13.9 and 6.07 µM. In relation to the selectivity index, 4ah and 4bn were, respectively, 22 and 15 times less toxic to macrophage cells than the control amphotericin B that showed SI = 0.75 (Table 2) .
The presence of the nitro group allied to the methylenedioxy group on the benzylic ring in 4bn increased the selectivity index, as evidenced by the much lower selectivity index of the compound 4bi. The presence of the CF 3 group in 4ah, smaller and more lipophilic, favored the increase of the selectivity index when compared to 4ae that has the OCH 3 and OBn groups on the phenyl ring.
Our results demonstrate the importance of the 1,4-dihydroquinolinic nucleus in the study of compounds with antileishmanial properties. Recent works have confirmed the interesting antileishmanial properties of quinoline derivatives (Antinarelli et al. 2015; Herrera et al. 2016; Navneetha et al. 2017) . In these works, various quinoline derivatives have been synthesized and showed results that attest to the importance of this pharmacophore nucleus for leishmanicidal activity against the promastigote form. However, few studies report the activity of 1,4-dihydroquinoline derivatives, which demonstrates that the potential of this class of compounds has not yet been adequately explored.
Conclusion
Thirty-five lactone 1,4-dihydroquinoline derivatives were submitted to antileishmanial assay against promastigote forms of L. (L.) amazonesis in vitro. Among the evaluated compounds, 4ah and 4bn showed promising in vitro antileishmanial activity and low toxicity in macrophage cells. These compounds are interesting targets that emerge among the various classes of compounds already synthesized and evaluated against leishmaniasis. The results obtained with these compounds are an additive justification for further studies of the lactone 1,4-dihydroquinoline derivatives against amastigote forms and may contribute to the search for new molecules as targets for the development of more potent and fewer side-effect drugs.
Materials and methods
Chemistry
A mixture of tetronic acid (1.0 mmol), benzaldehydes (1.0 mmol), and anilines (1.0 mmol) in ethanol (2 mL) was taken in a reaction flask equipped with a small magnetic stirring bar and the reflux condenser. The mixture was then irradiated in a microwave reactor for 15 min (reflux temperature of the solvent) at a power of 200 W. After the reaction was complete (TLC monitoring), the mixture was then cooled to room temperature and the solvent was removed on rotary evaporator. The precipitated crude product was washed with a mixture of hexane-ethyl acetate (8:2) and dried under vacuum. The variation of anilines (2a-c) and benzaldehydes (3a-n) furnished the lactone 1,4-dihydroquinolines 4aa-4cn in yields ranging from 69 to 92%. Data of characterization of the compounds were described by Laurentiz et al. (2018) . penicillin, and 50 mg·mL −1 streptomycin (Cultilab) in the presence of 100 µM of compounds previously dissolved in 100% dimethylsulfoxide (DMSO) (Synth). Cultures were incubated at 25°C in BOD (Quimis) for 24 h and the leishmanicidal activity was determined by growth inhibition of promastigote forms by counting the total number of live promastigotes in the Neubauer chamber (Global Glass), considering flagellar motility (Azzouz et al. 2005) . The compounds that showed greater than or equal to 80% inhibition of cell growth during 24 h were evaluated at concentrations of 1.00-100 µM. RPMI 1640 medium (Gibco) containing 0.5% DMSO (Synth) (highest concentration) was used as a negative control and amphotericin B (Eurofarma) at concentrations of 0.20-3.37 µM was used as a positive control. Two experiments were performed in triplicate and repeated twice. Determination of 50% inhibition concentration values (IC 50 ) was carried out by GraphPad Prism version 5.0 Windows software (GraphPad Software, USA) using a nonlinear regression model of variable slope.
Biological assays
Macrophages and cytotoxicity assay
Thioglycolate-elicited peritoneal macrophages were obtained from BALB/c mice (weighing 20-25 g) by injection of 500 µL of 3% thioglycolate 3 days prior to peritoneal lavage with 5 mL of ice-cold phosphate-buffered saline (PBS 1 × ). The peritoneal exudate cells were centrifuged at 400 × g for 10 min at 4°C, the supernatant was removed, and RPMI 1640 (Gibco) medium was supplemented with 10% FBS (Cultilab), 50 units·mL −1 penicillin, and 50 mg·mL −1 streptomycin (Cultilab) was added to the pellet (macrophages) (Toledo et al. 2014) . The experiment was authorized by the University of Franca´s Ethics Committee for Animal Care (approval number: 046/15). Macrophages (2 × 10 5 cells/well) were seeded in a 96-well microtiter plate and incubated at 37°C in a 5% CO 2 atmosphere for 24 h and when the macrophages had developed a monolayer, the cells were exposed with the compounds at concentrations of 1.60 to 200 µM (4ae, 4ah, 4bi, and 4bn) or 0.20-3.38 µM (amphotericin B) for 24 h. The morphological changes of treated and untreated cell lines (control) were compared by monitoring, using an inverted microscope (Axio Vert, Carl Zeiss). Cell viability was determined using the vital stain Trypan Blue (Aldrich) at 0.1% concentration in phosphate buffer (Mesa-Valle et al. 1996) . The number of dead cells was recorded, and the percentage of viability was determined as [no. of viable cells in the cells treated/no. of viable cells in the cells not treated (negative control)] × 100. RPMI 1640 medium (Gibco) containing 0.5% DMSO (Synth) (highest concentration) was used as a negative control and 25% DMSO was used as a positive control. Two experiments were performed in triplicate and repeated twice. Determination of 50% cytotoxic concentration values (CC 50 ) was carried out by GraphPad Prism version 5.0 Windows software (GraphPad software, USA) using a nonlinear regression model of variable slope.
